試験の準備方法-有難いCCDM資格復習テキスト試験-100％合格率のCCDM受験体験

Wiki Article

さらに、Topexam CCDMダンプの一部が現在無料で提供されています：https://drive.google.com/open?id=11YMzE38XiQl9Gp-Vht4N-H3wvIAa-Ij4

Topexamさまざまな試験（CCDM試験など）の準備中に生産性を上げるのに無力だと感じたとき。 散発的な時間を最大限に活用し、先延ばしを避けることが困難な場合。 これらの煩わしさを解決し、より効率的かつ生産的な方法でCCDM証明書を取得するのに役立つCCDMテスト準備の重要性を認識する時が来ました。 SCDMのCCDM試験の質問で20〜30時間学習する限り、CCDM試験を確実にCertified Clinical Data Manager受験して合格することができます。

SCDM CCDM 認定試験の出題範囲：

トピック出題範囲
トピック 1
  • データ処理タスク: このセクションでは、臨床システムアナリストのスキルを測定し、データライフサイクル全体にわたって品質、一貫性、適切な権限を維持しながら、研究データの処理、変換、統合、調整、コーディング、クエリ、更新、アーカイブ化に焦点を当てます。
トピック 2
  • 設計タスク: CCDM 試験のこのセクションでは、データ マネージャーのスキルを測定し、データ収集機器の設計と文書化、ワークフローとデータ フローの開発、データ要素、CRF フォーム、編集チェック、レポート、データベース構造の指定、追跡可能性と監査可能性の標準と手順の定義方法について学習します。
トピック 3
  • レビュータスク: このセクションでは、データ マネージャーのスキルを測定し、プロトコル、CRF、データ テーブル、リスト、図、臨床試験レポート (CSR) をレビューして、一貫性、正確性、およびデータ処理の定義と規制要件との整合性を確認します。
トピック 4
  • 調整とプロジェクト管理タスク: このドメインでは、データ管理ワークロード、ベンダーの選択、スケジュール、チーム間のコミュニケーション、プロジェクト タイムライン管理、リスク処理、メトリックの追跡、監査の準備の調整における臨床システム アナリストのスキルを評価します。
トピック 5
  • テストタスク: このセクションでは、データ マネージャーのスキルを測定します。テスト計画の作成、テスト データの生成、検証およびユーザー受け入れテストの実行、およびシステムとプロセスが確実に仕様どおりに実行されるようにするための結果の文書化が含まれます。

>> CCDM資格復習テキスト <<

信頼できるCCDM資格復習テキスト & 合格スムーズCCDM受験体験 | 便利なCCDM日本語学習内容

TopexamのCCDM試験トレントの合格率は、効果的で有用を証明する唯一の基準であるというのは常識です。 CCDM試験問題の利点についての一般的な考えは既にお持ちのことと思いますが、CCDMガイドトレントの最大の強みである最高の合格率をお見せしたいと思います。 SCDM統計によると、CCDMガイドトレントのガイダンスに従って試験を準備したお客様の合格率は、98〜100％に達し、CCDM試験トレントを20〜30時間しか練習していません。

SCDM Certified Clinical Data Manager 認定 CCDM 試験問題 (Q58-Q63):

質問 # 58
A statistician analyzes data from a randomized, double-blind, placebo-controlled study and finds that the placebo outperformed the investigational product. Which of the following is a plausible explanation for this?

正解：C

解説：
In a randomized, double-blind, placebo-controlled study, if statistical analysis shows that the placebo appears to outperform the investigational product, a likely cause is a data management or coding error, particularly in treatment code entry or mapping.
According to the GCDMP (Chapter: Database Design and Build), treatment assignment data - typically stored in randomization or code-break files - must be accurately integrated into the clinical database. Any mismatch between randomization codes, subject identifiers, or treatment arms can lead to incorrect grouping during analysis, producing false conclusions such as placebo superiority.
The Data Manager should initiate a root cause review of randomization data integration and treatment mapping. The placebo is never designed to have active medicinal effects (option A). Option D is incorrect because the described scenario implies a data inconsistency, not true efficacy differences. Proper verification of randomization coding and reconciliation between data management and statistical programming systems are essential.
Reference (CCDM-Verified Sources):
SCDM Good Clinical Data Management Practices (GCDMP), Chapter: Database Design and Build, Section 6.1 - Randomization and Treatment Code Management ICH E6 (R2) GCP, Section 5.5.3 - Data Verification and Coding Accuracy FDA Guidance for Industry: Computerized Systems Used in Clinical Investigations - Data Mapping and Validation Requirements


質問 # 59
Which of the following processes is the most likely to remain in a study that utilizes electronic data capture?

正解：D

解説：
In studies utilizing Electronic Data Capture (EDC) systems, many traditional paper-based processes such as tracking and retrieving CRFs are eliminated or automated. However, query management and resolution remain essential because discrepancies, missing data, and protocol deviations still require clarification and correction, regardless of the data collection medium.
According to the GCDMP (Chapter: Data Validation and Cleaning), data queries are generated automatically or manually when inconsistencies are detected by edit checks. Sites must still respond to these queries electronically to ensure the integrity and completeness of data.
A and D are obsolete with EDC (no physical CRFs).
B refers to manual data entry updates, which are replaced by direct EDC entry.
C (Resolving queries) continues as a key part of the data management workflow, even in fully electronic environments.
Thus, option C is correct.
Reference (CCDM-Verified Sources):
SCDM GCDMP, Chapter: Data Validation and Cleaning, Section 5.4 - Query Generation and Resolution in EDC Systems ICH E6(R2) GCP, Section 5.5.3 - Data Review and Query Resolution Requirements FDA 21 CFR Part 11 - Electronic Records: Audit Trails and Query Documentation C


質問 # 60
A Data Manager is establishing a timeline for database lock for a 100-person study where the data have been maintained almost all clean throughout the study. All data from external labs have been received and reconciled. Which is the best estimate of the amount of time needed to lock the database after Last Patient Last Visit?

正解：D

解説：
For a well-maintained 100-subject study with ongoing data cleaning and completed reconciliations, the database lock process typically takes a few days after the Last Patient Last Visit (LPLV).
According to the GCDMP (Chapter: Database Lock and Archiving), the duration of the lock process depends on the level of data cleanliness at LPLV. If the study team has conducted continuous data cleaning, query resolution, and external data reconciliation throughout the trial, then the final lock steps (e.g., final data review, documentation, and approvals) can be completed in 2-5 days.
However, if significant cleaning or reconciliation remains outstanding, lock may take several weeks. Since the question states that data are "maintained almost all clean," Option B - a few days - is the appropriate estimate.
Reference (CCDM-Verified Sources):
SCDM Good Clinical Data Management Practices (GCDMP), Chapter: Database Lock and Archiving, Section 6.2 - Database Lock Preparation and Timelines ICH E6 (R2) Good Clinical Practice, Section 5.5.3 - Data Quality and Lock Procedures FDA Guidance for Industry: Computerized Systems Used in Clinical Investigations - Data Lock and Archiving Procedures


質問 # 61
Data characterizing the safety profile of a drug are collected to provide information for which of the following?

正解：D

解説：
Safety data collected during a clinical trial are used primarily to support product labeling, ensuring accurate communication of a drug's risks, contraindications, and adverse reactions to healthcare providers and patients.
According to the GCDMP (Chapter: Safety Data Handling and Reconciliation) and ICH E2A/E2F guidelines, all adverse events (AEs), serious adverse events (SAEs), and laboratory abnormalities are analyzed and summarized to define the safety profile of an investigational product. These data form the basis for regulatory submissions such as the Clinical Study Report (CSR) and product labeling (e.g., prescribing information), as required by the FDA and other regulatory authorities.
While safety data may contribute indirectly to analyses such as survival curves (option A) or quality of life metrics (option D), their primary regulatory function is to inform product labeling and post-marketing surveillance documentation.
Reference (CCDM-Verified Sources):
SCDM Good Clinical Data Management Practices (GCDMP), Chapter: Safety Data Handling and Reconciliation, Section 4.3 - Use of Safety Data in Regulatory Submissions ICH E2A - Clinical Safety Data Management: Definitions and Standards for Expedited Reporting FDA Guidance for Industry: Adverse Event Reporting and Labeling Requirements


質問 # 62
In reviewing the adverse events for a subject, a data manager notices one recorded as "worsening of migraine." After reviewing the rest of the adverse events and finding no other migraine recordings, what is the data manager's next step?

正解：A

解説：
When a data inconsistency arises - such as a record of "worsening of migraine" without prior documentation of a migraine episode - the Data Manager should query the site for clarification (Option D).
According to the GCDMP (Chapter: Data Validation and Cleaning), data managers must raise a clarification query whenever data appear incomplete, inconsistent, or ambiguous. The site must confirm whether "worsening of migraine" refers to a new event or an exacerbation of a preexisting condition. This clarification ensures accurate safety reporting and appropriate medical coding (e.g., MedDRA classification).
Checking the medical history (Option C) may help but does not resolve the inconsistency. Assuming a relationship (Option A or B) without verification would violate Good Clinical Data Management Practice and potentially misrepresent the adverse event.
Reference (CCDM-Verified Sources):
SCDM Good Clinical Data Management Practices (GCDMP), Chapter: Data Validation and Cleaning, Section 6.3 - Query Generation and Resolution ICH E2A - Clinical Safety Data Management: Definitions and Standards for Expedited Reporting, Section II - Data Clarification Requirements FDA Guidance for Industry: Computerized Systems Used in Clinical Investigations - Data Query Management


質問 # 63
......

Topexamは、SCDM期待されるスコアを達成してCCDM認定を取得する価値のあるクライアントにチャンスを与えるための非常に素晴らしい効果的なプラットフォームです。 プロの専門家のたゆまぬ努力により、CCDM試験トレントには、タイミング機能を備えた模擬試験システムが装備されており、Certified Clinical Data Manager学習結果をいつでも確認し、欠陥をチェックし続け、体力を改善できます。 あなたが学生であろうとオフィスワーカーであろうと、ここで満足することができ、CCDM試験トレントを選択しても後悔することはありません。

CCDM受験体験: https://www.topexam.jp/CCDM_shiken.html

さらに、Topexam CCDMダンプの一部が現在無料で提供されています：https://drive.google.com/open?id=11YMzE38XiQl9Gp-Vht4N-H3wvIAa-Ij4

Report this wiki page